The intelligence of machines and the branch of computer science which aims to create it

Artificial Intelligence Journal

Subscribe to Artificial Intelligence Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Artificial Intelligence Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Artificial Intelligence Authors: William Schmarzo, Ed Featherston, Dan Blacharski, Corey Roth, Jnan Dash

Related Topics: Artificial Intelligence Journal, Fitness Journal, Mergers & Acquisitions on Ulitzer, Sarbanes Oxley on Ulitzer

News Feed Item

Price Movements, Earnings Release Schedules, Acquisitions, Repurchase Programs and Dividends - Analyst Notes on PPG, Valspar, BioFuel, Westlake and Platform

Editor Note: For more information about this release, please scroll to bottom

NEW YORK, April 23, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding PPG Industries Inc. (NYSE: VAL), The Valspar Corporation (NYSE: VAL), BioFuel Energy Corp. (NASDAQ: BIOF), Westlake Chemical Corp. (NYSE: WLK) and Platform Specialty Products Corporation (NYSE: PAH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1454-100free.

--
PPG Industries Inc. Analyst Notes
On April 17, 2014, PPG Industries Inc. (PPG) announced that the Company's Board has authorized a repurchase of $2 billion of outstanding common stock, effective immediately. The authorization does not expire and gives management discretion in determining the conditions under which shares may be purchased. Additionally, the Board has also approved a 10% increase on the Company's dividend, declaring a regular quarterly dividend of $0.67 per share. The dividend is payable on June 12, 2014 to shareholders of record on May 12, 2014. This also marks the Company's 463rd consecutive dividend payment. The full analyst notes on PPG are available to download free of charge at:

http://www.analystsreview.com/1454-VAL-23Apr2014.pdf

--
The Valspar Corporation Analyst Notes
On April 17, 2014, The Valspar Corp. (Valspar) stock increased 2.66% to end the day at $73.28 compared to the previous day's closing price of $71.38. The Company's stock gained 2.22% over the past three months compared to the Dow Jones Industrial Average which fell 0.30% and to Standard & Poor's 500 which increased 1.41% during the same period. The full analyst notes on Valspar are available to download free of charge at:

http://www.analystsreview.com/1454-VAL-23Apr2014.pdf

--
BioFuel Energy Corp. Analyst Notes
On April 17, 2014, BioFuel Energy Corp. (BioFuel) stock increased 27.39% to end the day at $7.72 compared to the previous day's closing price of $6.06. The Company's stock advanced 49.32% over the past three trading days compared to the Nasdaq Composite which went up 1.81% during the same period. The full analyst notes on BioFuel are available to download free of charge at:

http://www.analystsreview.com/1454-BIOF-23Apr2014.pdf

--
Westlake Chemical Corp. Analyst Notes
On April 15, 2014, Westlake Chemical Corp. (Westlake) announced the schedule of its earnings release. The Company will report its Q1 2014 financial results in a conference call on May 5, 2014, Monday at 11:00 a.m. CT. The conference call will be available via webcast at the Company's website. The full analyst notes on Westlake are available to download free of charge at:

http://www.analystsreview.com/1454-WLK-23Apr2014.pdf

--
Platform Specialty Products Corporation Analyst Notes
On April 17, 2014, Platform Specialty Products Corp. (Platform) announced that it has entered into a definitive agreement to acquire Chemtura AgroSolutions (CAS) from Chemtura Corporation for approximately $1 billion. CAS is a leading provider of seed treatment and agrochemical products for a wide variety of crop applications in attractive geographies. Additionally, Platform and Chemtura have entered into a long-term supply agreement where Chemtura will supply key AI's and Platform will supplement this with select acquisition and licensing of others AI's to take advantage of CAS' global registrations and distribution footprint. The transaction is expected to close in H2 2014. The full analyst notes on Platform are available to download free of charge at:

http://www.analystsreview.com/1454-PAH-23Apr2014.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Analysts Review

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.